Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model

John P. Hanley, Huy A. Tu, Julie A. Dragon, Dorothy M. Dickson, Roxana del Rio-Guerra, Scott W. Tighe, Korin M. Eckstrom, Nicholas Selig, Samuel V. Scarpino, Stephen S. Whitehead, Anna P. Durbin, Kristen K. Pierce, Beth D. Kirkpatrick, Donna M. Rizzo, Seth Frietze, Sean A. Diehl

Research output: Contribution to journalArticlepeer-review


About 20–25% of dengue virus (DENV) infections become symptomatic ranging from self-limiting fever to shock. Immune gene expression changes during progression to severe dengue have been documented in hospitalized patients; however, baseline or kinetic information is difficult to standardize in natural infection. Here we profile the host immunotranscriptome response in humans before, during, and after infection with a partially attenuated rDEN2Δ30 challenge virus ( NCT02021968). Inflammatory genes including type I interferon and viral restriction pathways are induced during DENV2 viremia and return to baseline after viral clearance, while others including myeloid, migratory, humoral, and growth factor immune regulation factors pathways are found at non-baseline levels post-viremia. Furthermore, pre-infection baseline gene expression is useful to predict rDEN2Δ30-induced immune responses and the development of rash. Our results suggest a distinct immunological profile for mild rDEN2Δ30 infection and offer new potential biomarkers for characterizing primary DENV infection.

Original languageEnglish (US)
Article number3054
JournalNature communications
Issue number1
StatePublished - May 24 2021

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • General
  • Physics and Astronomy(all)


Dive into the research topics of 'Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model'. Together they form a unique fingerprint.

Cite this